IDiyas

For the Inventor, By the Inventor

Oregonia, OH, United States of America

Michael John Janusz

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • West Chester, OH (US) (2019)
  • Oregonia, OH (US) (1995 - 2024)

Company Filing History:

goldMedal6 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
silverMedal2 out of 17,164 
 
The Procter Gamble Company
 patents
bronzeMedal2 out of 14 
 
Alimentary Health Limited
 patents
4. 1 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents
5. 1 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
6. 1 out of 15 
 
International N&h Denmark Aps
 patents
where one patent can have more than one assignee

Years Active: 1995-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12059441 - Probiotic bacterial strains that produce short chain fatty acids and compositions comprising same (2024-08-13),
2. 10519430 - (2019-12-31),
3. 10233433 - [object Object] (2019-03-19),
4. 7087615 - 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia (2006-08-08),
5. 6953788 - 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase (2005-10-11),
6. 6770640 - 1-Carboxylmethyl-2-oxo-azepan derivatives useful as selective inhibitors of MMP-12 (2004-08-03),
7. 6544980 - N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase (2003-04-08),
8. 6352976 - Selective inhibitors of MMP-12 (2002-03-05),
9. 6329550 - Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase (2001-12-11),
10. 6262080 - 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase (2001-07-17),
11. 5510333 - Inhibitors of Cathepsin G and elastase for preventing connective tissue (1996-04-23),
12. 5384119 - Method of preventing neutrophil mediated connective tissue damage (1995-01-24),

Title: Unveiling the Innovative Mind of Inventor Michael John Janusz

Introduction:

Michael John Janusz, a revered inventor hailing from Oregonia, Ohio, has made significant contributions to the field of patents with an impressive portfolio of 11 patents to his name. His relentless pursuit of innovation has led to groundbreaking discoveries that have shaped the world of ingestible formulations.

Latest Patents:

Among his latest patents is a revolutionary formulation comprising an ingestible carrier and an isolated strain of a groundbreaking element. The innovative nature of his patents underscores his commitment to pushing the boundaries of traditional research and development.

Career Highlights:

Having worked at esteemed companies such as Aventis Pharmaceuticals Inc. and The Procter & Gamble Company, Michael John Janusz has honed his expertise in the realm of pharmaceuticals and consumer goods. His experience at these industry giants has equipped him with the knowledge and skills necessary to drive forward cutting-edge inventions.

Collaborations:

Throughout his career, Michael John Janusz has collaborated with visionary individuals such as Alan M. Warshawsky and Gary A. Flynn. Their synergistic efforts have paved the way for transformative inventions that have garnered acclaim within the scientific community.

Conclusion:

In conclusion, Michael John Janusz stands as a beacon of innovation within the realm of patents. His unwavering dedication to pioneering new solutions and his collaborative spirit exemplify the essence of a true inventor. We look forward to witnessing the continued impact of his inventive spirit on future generations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…